United States

Securities and Exchange Commission

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

March 5, 2010

 

Prospect Medical Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

1-32203

 

33-0564370

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

10780 Santa Monica Blvd., Suite 400

 

 

Los Angeles, California

 

90025

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (310) 943-4500

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07                                            Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders of Prospect Medical Holdings, Inc. (“we,” “us,” “our,” or the “Company”) was held on March 5, 2010.  The stockholders considered three proposals, each of which is described in more detail in our definitive proxy statement dated February 8, 2010.

 

Proposal 1: Approval of a proposal to amend our Certificate of Incorporation to provide for a classified Board of Directors.

 

FOR

 

AGAINST

 

ABSTAIN

 

15,021,113

 

3,127,180

 

27,221

 

 

Broker Non-Votes: 0

 

The foregoing proposal was approved by affirmative vote of a majority of the 20,792,520 shares of our common stock outstanding as of the record date for the Annual Meeting.

 

Proposal 2: Election of five directors to hold office, subject to the approval of Proposal 1, above, until the Annual Meeting for the year, indicated below, in which such Class of directors expires:

 

 

 

Class

 

FOR

 

WITHHELD

 

Samuel S. Lee

 

2013

 

9,591,958

 

435,931

 

David Levinsohn

 

2011

 

9,593,325

 

434,564

 

Jeereddi Prasad, M.D.

 

2012

 

9,592,287

 

435,602

 

Glenn R. Robson

 

2012

 

9,593,465

 

434,424

 

Kenneth Schwartz

 

2011

 

9,593,465

 

434,424

 

 

Broker Non-Votes: 0

 

All of the foregoing candidates were elected by affirmative vote of a majority of the shares voted at the Annual Meeting.

 

Proposal 3:  Ratification of the selection of BDO Seidman, LLP as our independent public accountant for the fiscal year ending September 30, 2010:

 

FOR

 

AGAINST

 

ABSTAIN

 

13,266,470

 

26,278

 

2,000

 

 

Broker Non-Votes: 0

 

The foregoing proposal was approved by affirmative vote of a majority of the shares voted at the Annual Meeting.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PROSPECT MEDICAL HOLDINGS, INC.

 

 

 

 

 

By:

/s/ MIKE HEATHER

 

 

Mike Heather

 

 

Chief Financial Officer

 

Dated: March 10, 2010

 

3